Article
Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA
27 May 2004
Abstract excerpt
A previously unknown coronavirus (CoV) is the aetiological agent causing severe acute respiratory syndrome (SARS), for which an effective antiviral treatment is urgently needed. To enable the rapid and biosafe identification of coronavirus replicase inhibitors, we have generated a non-cytopathic, selectable replicon RNA (based on human CoV 229E) that can be stably maintained in eukaryotic cells. Most importantly,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.